pharma · Epilepsy · Allergic Reaction · AQST
Aquestive Therapeutics
Aquestive Therapeutics is a pharma organization headquartered in Vancouver, CA. It trades on NYSE under ticker AQST. Primary therapeutic focus areas include Epilepsy, Allergic Reaction, Nausea and Vomiting, Postoperative
Vancouver, CA HQ
2009 Founded
75 Employees
Public company Type
AQST · NYSE Ticker
Company details
- Status
- Public
- HQ
- Vancouver, CA
- Founded
- 2009
- Employees
- 75
- Programs
- 9
- Drugs
- 9
- Patents
- 17
Ondansetron 8 mg ODFS without water
Phase 1 · small molecule · Healthy Participants
Ondansetron 8 mg ODFS without water for Healthy Participants is a Phase 1 program (small_molecule) at Aquestive Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code OND/CR/051/08/09
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Aquestive Therapeutics
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Healthy Participants
- Status
- completed
- Trials
- 1